Skip to content

Drug interactions

Fondaparinux + Ibrutinib

Severity: Major

Fondaparinux and Ibrutinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ibrutinib impairs platelet function and is associated with bleeding events, including serious hemorrhage. Adding an anticoagulant increases that risk further.

What this interaction means in plain words

Fondaparinux and Ibrutinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Fondaparinux belongs to Cardiovascular; Ibrutinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Ibrutinib inhibits BTK-dependent platelet signaling, adding to fondaparinux inhibition of factor Xa.

What to do

Avoid combining when possible, or monitor closely for bleeding with careful assessment of benefit. Ibrutinib labeling advises holding it around surgery.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fondaparinux and Ibrutinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fondaparinux with Ibrutinib?

MediHelp rates the interaction as major. Fondaparinux and Ibrutinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ibrutinib impairs platelet function and is associated with bleeding events, including serious hemorrhage. Adding an anticoagulant increases that risk further.

How serious is the interaction between Fondaparinux and Ibrutinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining when possible, or monitor closely for bleeding with careful assessment of benefit. Ibrutinib labeling advises holding it around surgery.

What other medicines interact with Fondaparinux?

MediHelp also lists interactions of Fondaparinux with, for example, Defibrotide, Ketorolac, Abciximab. The full list is on the Fondaparinux page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in